Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
about
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug.Tumor progression: the neuronal input.Drug Repositioning in Glioblastoma: A Pathway Perspective.Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastasesDevelopments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
P2860
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@ast
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@en
type
label
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@ast
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@en
prefLabel
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@ast
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@en
P2093
P2860
P356
P1433
P1476
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges
@en
P2093
DO-Hyun Nam
Jeongwu Lee
Jin-Ku Lee
P2860
P304
P356
10.3892/OL.2016.4074
P577
2016-01-07T00:00:00Z